Herbas VPB

Print
EN | LT
Supplementary protection
LT - Didinamos dozės fermentų pakaitinė terapija, skirta rūgštinės sfingomielinazės nepakankamumui gydyti
EN - DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY
SPC
(11) Number of the document C 3482767
(68) Number of the document 3482767
(21) Application number for Supplementary Protection Certificate PA 2022 526
(22) Date of filing the application 2022-12-06
(41) Date of publication of the application 2022-12-27
Date of publication of SPC 2024-03-25
(24) Date of coming into effect of SPC 2030-08-29
Applicant
(71) Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029, US
Genzyme Corporation , 450 Water Street, Cambridge, MA 02141, US
Grantee
(73) Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029, US
Genzyme Corporation , 450 Water Street, Cambridge, MA 02141, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/22/1659, 2022-06-24
Calculated date of expiry of the SPC
(94) 2035-08-28
Name of the product protected by the basic patent
(95) Olipudazė alfa
Legal status
SPC granted
Last update date 2024-03-22